Karla Palmer is a lawyer at the largest FDA law firm in the United States, Hyman Phelps, where she focuses on DEA and FDA enforcement and litigation. Ms. Palmer advises clients throughout the supply chain – from manufacturers and distributors to outsourcing facilities, pharmacies and doctors – on a range of issues, including DEA and FDA regulations and guidance, government inspections (including Form 483s) and investigations, warning letters, consent decrees, and administrative and federal proceedings. She has also handled administrative proceedings at the DEA involving, but not limited to, registrant revocation actions, including the appeal of those matters in federal courts. In addition, she has written about and addressed industry audiences across the country on all aspects of the passage and implementation of the 2013 Drug Quality and Security Act including both compounding and supply chain issues, its guidance documents, and implementing regulations. She is well versed in compounding laws, regulations and guidance, and regularly counsels clients on these topics.